Document Detail


New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
MedLine Citation:
PMID:  20675960     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The critical role played by the renin-angiotensin-aldosterone system (RAAS) in the regulation of blood pressure and body fluid homeostasis has been well recognized. Angiotensin (Ang) II and aldosterone are the most powerful biologically active products of the RAAS, although there are also other bioactive Ang peptides involved in this system, including AngIII, AngIV, and Ang1-7. In addition to their physiological roles, AngII and aldosterone induce inflammation, cell growth, mitogenesis, apoptosis, migration, and differentiation; regulate gene expression of bioactive substances; and activate multiple intracellular signaling pathways, all of which contribute to cardiovascular tissue injury. During the last decade, both clinical and preclinical studies have demonstrated that various pharmacological interventions of the RAAS exert blood pressure-independent cardiovascular-protective effects. In this Forum Minireview entitled "New approaches to blockade of the renin-angiotensin-aldosterone system", we will discuss the impact of RAAS inhibitors on prevention of the development of hypertension and cardiovascular diseases. Before going into details about the insights into RAAS inhibition that each of the four groups will provide, we herein briefly overview our current understanding of regulation of the circulating RAAS.
Authors:
Akira Nishiyama; Shokei Kim-Mitsuyama
Publication Detail:
Type:  Journal Article; Review     Date:  2010-07-27
Journal Detail:
Title:  Journal of pharmacological sciences     Volume:  113     ISSN:  1347-8648     ISO Abbreviation:  J. Pharmacol. Sci.     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-20     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101167001     Medline TA:  J Pharmacol Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  289-91     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Faculty of Medicine, Kagawa University, Japan. akira@kms.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone / pharmacology
Angiotensin II / pharmacology
Humans
Receptor, Angiotensin, Type 1 / metabolism
Renin-Angiotensin System / drug effects*
Chemical
Reg. No./Substance:
0/Receptor, Angiotensin, Type 1; 11128-99-7/Angiotensin II; 52-39-1/Aldosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New approaches to blockade of the renin-angiotensin-aldosterone system: characteristics and usefulne...
Next Document:  Epigenetic characteristics of paternal chromatin in interspecies zygotes.